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Evaluate the impact of polymerase chain reaction (PCR) rapid diagnostic testing
on time to de-escalation of antibiotic therapy
in methicillin sensitive staphylococcus aureus (MSSA) bacteremia
Nydia I. Rivera-Berríos, PharmD; Maria Pérez-Arias, PharmD; Katia Abaunza, MT,ASCP; Julie A. Lamoureux, MSc, DMD

The electronic health record (EHR) was used to collect:

Background
• Use of antimicrobials including broad-spectrum antibiotics
has increased significantly over the years resulting in a rise in
resistance.
• The Infectious Disease Society of America supports the use
of rapid diagnostic testing to improve antibiotic utilization.
• Staphylococcus aureus (MSSA) and Methicillin-resistant
Staphylococcus aureus (MRSA) are common pathogens that
cause bloodstream infections.
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• Vancomycin is often prescribed empirically until the strain
can be identified and in cases of MSSA de-escalated to a
more narrow spectrum antibiotic.
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• Thus, rapid identification of staphylococcal species and
methicillin susceptibility has important implications in guiding
early optimal antibiotic therapy.
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Purpose
Determine if time to de-escalation of therapy is shortened
when methicillin sensitive staphylococcus aureus (MSSA) is
identified by rapid polymerase chain reaction (PCR) assay
compared to the conventional method of organism
identification by culture and sensitivity (C&S).

Methods
A quality assurance, retrospective cohort study was
conducted.
Blood cultures positive for MSSA species
detected, by both polymerase chain reaction (PCR) rapid
diagnostic testing and by conventional clinical microbiology
procedures (C&S), were identified from the laboratory data
base.
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 The data collection tool of the study will consist of a
questionnaire that include patient demographic
information and questions about pain perception
and anxiety experienced with IV insertion.

Preliminary Findings

The table below shows the descriptive statistics for the 2
groups: Conventional C&S and PCR.
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The median time from culture collection to therapy deescalation (compared using a Wilcoxon rank test) was
significantly shorter in the PCR group compared to
Conventional C&S group (z = 4.125, p < 0.001).
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The median time to results (compared using a Wilcoxon rank
test) was significantly shorter in the PCR group compared to
the Conventional C&S group (z = 4.234, p < 0.001).
Ten of the 12 cases (83.3%) in the PCR group were deescalated to an antibiotic with narrower spectrum whereas 19
of the 29 cases (65.5%) for the Conventional C&S group were
de-escalated. These two proportions (compared using a chisquare test) were not statistically significantly different
between the two groups (χ21df = 1.301, p = 0.254).
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Conclusion
Preliminary data suggests a reduction in time to de-escalation
of antibiotic therapy for methicillin sensitive staphylococcus
bacteremias as a result of implementing PCR rapid diagnostic
testing. However, more data is needed to successfully
determine the impact on antibiotic consumption.

Implications for Practice
• Improve time for optimal treatment of MSSA
• Reduce the unnecessary use of Vancomycin
• Decrease the resistance to antibiotics
• Decrease the use of broad-spectrum antibiotics
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